Logo Logo
Switch Language to German

Dominik, Modest; Ludwig, Fischer von Weikersthal; Thomas, Decker; Ursula, Vehling-Kaiser; Jens, Uhlig; Michael, Schenk; Jens, Freiberg-Richter; Bettina, Peuser; Claudio, Denzlinger; Christina, Peveling Genannt Reddemann; Ullrich, Graeven; Gunter, Schuch; Ingo, Schwaner; Arndt, Stahler; Andreas, Jung; Swantje, Held; Sebastian, Stintzing; Clemens, Giessen-Jung and Volker, Heinemann (2017): Randomized phase III study of fluoropyrimidine (FP) plus bevacizumab (BEV) vs. FP plus irinotecan (IRI) and BEV as first-line therapy for metastatic colorectal cancer (mCRC): German AIO KRK0110 (ML22011)- study. In: Annals of Oncology, Vol. 28

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item